Skip to main content
. 2021 Dec 25;33(1):194–205. doi: 10.1021/acs.bioconjchem.1c00537

Figure 5.

Figure 5

All ligands clearly visualize PSMA-positive tumors using both μSPECT/CT and fluorescence imaging. Representative μSPECT/CT scans (A) and fluorescence images (B) of mice with s.c. LS174T-PSMA (right) and wild-type LS174T (left) tumors after i.v. injection of 111In- (10 MBq/mouse) or 99mTc-labeled (15 MBq/mouse) ligands (0.3 nmol, 2 h p.i.).